✦ LIBER ✦

Obinutuzumab

Book ID: 125390011
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2014
Weight: 219 KB
Volume: 1503
Category: Article
ISSN: 0114-9954
DOI: 10.1007/s40278-014-1146-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Obinutuzumab: First Global Approval

✍ Cameron, Fiona; McCormack, Paul L. 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 255 KB

Obinutuzumab for B-cell malignancies

✍ Owen, Carolyn J; Stewart, Douglas A 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 300 KB

Obinutuzumab cost effective as first-lin

Obinutuzumab cost effective as first-line therapy in CLL

📂 Article 📅 2014 🏛 Adis International Limited (now part of Wolters Kl ⚖ 199 KB

Obinutuzumab plus Chlorambucil in Patien

Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions

✍ Goede, Valentin; Fischer, Kirsten; Busch, Raymonde; Engelke, Anja; Eichhorst, Ba 📂 Article 📅 2014 🏛 Massachusetts Medical Society 🌐 English ⚖ 650 KB

Update on obinutuzumab in the treatment

Update on obinutuzumab in the treatment of B-cell malignancies

✍ Illidge, Tim; Cheadle, Eleanor J; Donaghy, Claire; Honeychurch, Jamie 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 375 KB

Obinutuzumab: A Novel Anti-CD20 Monoclon

Obinutuzumab: A Novel Anti-CD20 Monoclonal Antibody for Previously Untreated Chronic Lymphocytic Leukemia

✍ Shah, A. 📂 Article 📅 2014 🏛 Harvey Whitney Books Company 🌐 English ⚖ 361 KB